课题基金 / 基金详情

Targeting P2X7 Receptor Antagonists for Prevention of Pancreatic Cancer

Targeting P2X7 Receptor Antagonists for Prevention of Pancreatic Cancer
靶向 P2X7 受体拮抗剂预防胰腺癌
批准号:
8760399
负责人:
TERISA DAVIS
金额:
$50.92万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

TERISA DAVIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall objective of this task order is to evaluate specific inhibitors of P2X7R for pancreatic cancer prevention in preclinical models. Specifically, the contractor shall test 2 such inhibitors (AZ10606120 (HAQDT) and A438079) by first establishing the optimal dose and maximal tolerated dose (MTD) in mice and then assess the pancreatic cancer prevention efficacy in p48Cre/+-LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer. In addition, test the modifications in inflammasome signal pathways and critical biomarkers of pharmacodynamic efficacy, which will be applicable to early-phase clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SCIENTIFIC SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE, DIVISIOIN OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS)
  • 批准号:
    10458431
  • 项目类别:
  • 资助金额:
    $222.97万
  • 财政年份:
    2020
  • 负责人:
    TERISA DAVIS
  • 依托单位:
SCIENTIFIC SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE, DIVISIOIN OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS)
  • 批准号:
    10225274
  • 项目类别:
  • 资助金额:
    $277.91万
  • 财政年份:
    2020
  • 负责人:
    TERISA DAVIS
  • 依托单位:
SCIENTIFIC SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE, DIVISIOIN OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS)
  • 批准号:
    10671441
  • 项目类别:
  • 资助金额:
    $269.22万
  • 财政年份:
    2020
  • 负责人:
    TERISA DAVIS
  • 依托单位:
Scientific Support Services for the National Cancer Institute, Division of Cancer Control and Population Sciences (DCCPS). POP 7/27/2019 - 7/26/2020.
  • 批准号:
    10039262
  • 项目类别:
  • 资助金额:
    $280.6万
  • 财政年份:
    2019
  • 负责人:
    TERISA DAVIS
  • 依托单位:
海外基金